Clovis Oncology, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2011 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Clovis Oncology, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2011 to Q3 2022.
  • Clovis Oncology, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2022 was $12M, a 26.2% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $12M -$4.26M -26.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $12.6M -$4.28M -25.4% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $13.1M -$5.64M -30.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $15.8M -$3.47M -18% Dec 31, 2021 10-Q 2022-11-09
Q3 2021 $16.3M -$3.84M -19.1% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $16.9M -$4.9M -22.5% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $18.7M -$4.09M -17.9% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $19.3M -$4.05M -17.4% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $20.1M -$890K -4.24% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $21.8M +$1.15M +5.57% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $22.8M +$1.64M +7.75% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $23.3M -$164K -0.7% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $21M -$1.78M -7.8% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $20.6M -$1.92M -8.51% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 $21.2M +$1.34M +6.73% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $23.5M +$3.97M +20.4% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $22.8M +$4.56M +25% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $22.5M -$25.1M -52.7% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $19.9M -$5.02M -20.2% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $19.5M +$17M +690% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $18.2M +$16.4M +900% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $47.6M +$44.8M +1561% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $24.9M +$16.8M +210% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $2.47M -$5.44M -68.8% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $1.82M -$13.8M -88.3% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $2.87M -$11.8M -80.5% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $8.03M -$5.44M -40.4% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $7.91M +$3.37M +74.2% Dec 31, 2015 10-K 2017-02-23
Q3 2015 $15.6M +$2.9M +22.8% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $14.7M +$10.2M +226% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $13.5M +$11M +439% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $4.54M +$3.79M +501% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $12.7M +$12M +1590% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $4.51M +$3.76M +500% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 $2.5M +$2.46M +6842% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $755K +$717K +1887% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $753K +$715K +1882% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $751K +$714K +1930% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $36K +$1K +2.86% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $38K +$4K +11.8% Dec 31, 2012 10-K 2014-02-28
Q3 2012 $38K Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $37K Jun 30, 2012 10-Q 2012-08-10
Q1 2012 $35K Mar 31, 2012 10-Q 2012-05-11
Q4 2011 $34K Dec 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.